Neutrophil-to-Lymphocyte Ratio and Early Variation of NLR to Predict In-Hospital Mortality and Severity in ED Patients with SARS-CoV-2 Infection

(1) Introduction: The neutrophil-to lymphocyte ratio is valued as a predictive marker in several inflammatory diseases. For example, an increasing NLR is a risk factor of mortality in sepsis. It also appears to be helpful in other settings such as cancer. The aim of our work was to study the prognostic value of NLR for disease severity and mortality in patients infected with SARS-CoV-2 upon their admission to the Emergency Department (ED) and its early variation (ΔNLR) in the first 24 h of management (H-24). (2) Methods: Between 1 March and 30 April 2020, we conducted a multicenter and retrospective cohort study of patients with moderate or severe coronavirus disease 19 (COVID-19), who were all hospitalized after presenting to the ED. (3) Results: A total of 1035 patients were included in our study. Factors associated with infection severity were C-reactive protein level (OR: 1.007, CI 95%: [1.005–1.010], p < 0.001), NLR at H-24 (OR: 1.117, CI 95%: [1.060–1.176], p < 0.001), and ΔNLR (OR: 1.877, CI 95%: [1.160–3.036], p: 0.01). The best threshold of ΔNLR to predict the severity of infection was 0.222 (sensitivity 56.1%, specificity 68.3%). In multivariate analysis, the only biochemical factor significantly associated with mortality was again ΔNLR (OR: 2.142, CI 95%: ([1.132–4.056], p: 0.019). The best threshold of ΔNLR to predict mortality was 0.411 (sensitivity 53.3%; specificity 67.3%). (4) Conclusion: The NLR and its early variation (ΔNLR) could help physicians predict both severity and mortality associated with SARS-CoV-2 infection, hence contributing to optimized patient management (accurate triage and treatment).

[1]  P. Raina,et al.  Inflammatory biomarkers as independent prognosticators of 28-day mortality for COVID-19 patients admitted to general medicine or ICU wards: a retrospective cohort study , 2021, Internal and Emergency Medicine.

[2]  Yibin Wang,et al.  The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19 , 2021, Cell Metabolism.

[3]  D. Bravata,et al.  Association of Intensive Care Unit Patient Load and Demand With Mortality Rates in US Department of Veterans Affairs Hospitals During the COVID-19 Pandemic , 2021, JAMA network open.

[4]  Zhi Mao,et al.  Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis , 2020, Critical Care.

[5]  Jianguo Gao,et al.  High neutrophil-to-lymphocyte ratio associated with progression to critical illness in older patients with COVID-19: a multicenter retrospective study , 2020, Aging.

[6]  M. Hémadi,et al.  Tissue damage from neutrophil-induced oxidative stress in COVID-19 , 2020, Nature Reviews Immunology.

[7]  Man Kong,et al.  Higher level of neutrophil-to-lymphocyte is associated with severe COVID-19 , 2020, Epidemiology and Infection.

[8]  A. Rout,et al.  Use of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 , 2020, Journal of clinical medicine research.

[9]  Alberto Borghetti,et al.  Neutrophil-to-lymphocyte ratio and clinical outcome in COVID-19: a report from the Italian front line , 2020, International Journal of Antimicrobial Agents.

[10]  Depei Wu,et al.  The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China , 2020, Thrombosis Research.

[11]  Y. Liu,et al.  Combined use of the neutrophil-to-lymphocyte ratio and CRP to predict 7-day disease severity in 84 hospitalized patients with COVID-19 pneumonia: a retrospective cohort study , 2020, Annals of translational medicine.

[12]  Jian-Ping Liu,et al.  The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients , 2020, International Immunopharmacology.

[13]  Amber Dance What is a cytokine storm? , 2020 .

[14]  Chuan Qin,et al.  Dysregulation of immune response in patients with COVID-19 in Wuhan, China , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  Zhiwei Huang,et al.  Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: A meta-analysis. , 2019, The American journal of emergency medicine.

[16]  C. Rosales Neutrophil: A Cell with Many Roles in Inflammation or Several Cell Types? , 2018, Front. Physiol..

[17]  A. Mangoni,et al.  Neutrophil to lymphocyte ratio and clinical outcomes in COPD: recent evidence and future perspectives , 2018, European Respiratory Review.

[18]  A. Pulvirenti,et al.  Neutrophil‐To‐Lymphocyte Ratio: An Emerging Marker Predicting Prognosis in Elderly Adults with Community‐Acquired Pneumonia , 2017, Journal of the American Geriatrics Society.

[19]  S. Hwang,et al.  Neutrophil‐to‐lymphocyte ratio as a prognostic marker in critically‐ill septic patients☆ , 2017, The American journal of emergency medicine.

[20]  E. Gayat,et al.  Reversal of neutrophil-to-lymphocyte count ratio in early versus late death from septic shock , 2015, Critical Care.

[21]  L. Celi,et al.  The association between the neutrophil-to-lymphocyte ratio and mortality in critical illness: an observational cohort study , 2015, Critical Care.

[22]  Ben Tran,et al.  Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. , 2014, Journal of the National Cancer Institute.

[23]  S. Clarke,et al.  The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. , 2013, Critical reviews in oncology/hematology.

[24]  T. van der Poll,et al.  Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit , 2010, Critical care.